Obesity, adipokines and their relationship with insulin resistance
Resumen
Obesity is one of the main health problems worldwide. It is a disease that is associated with excessive food consumption, although it is also associated with a process of chronic inflammation and with a group of disorders known as metabolic syndrome. Some of the most distinctive characteristics of obesity are that the individual's adipocytes are hypertrophied, have an irregular adipokine secretion profile, have increased recruitment of inflammatory cells, and altered metabolic homeostasis; which eventually results in the development of various important pathologies or conditions, such as insulin resistance and mitochondrial dysfunction. This review aims to present the current knowledge on inflammation of adipose tissue associated with obesity.
Descargas
Citas
Aguilar-Valles, A., Inoue, W., Rummel, C. & Luheshi, G. N. (2015). Obesity, adipokines and neuroinflammation. Neuropharmacology, 96(1), 124-134. DOI: 10.1016/j.neuropharm.2014.12.023.
Almeida-Sachet, C. P., Graham, A., Chen, Y. & Deusto, P. (2017). Behavioral changes in male mice fed a high-fat diet are associated with IL-1β expression in specific brain regions. Physiol Behav, 169(1), 130-140. DOI: 10.1016/j.physbeh.2016.11.016.
Anzalone, D. A. & Tuck, M. L. (1997). Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension, 30(1), 140-145. DOI: 10.1161/01.hyp.30.1.140.
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z. W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J. & Karin, M. (2005). IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med, 11(2), 191-198. DOI: 10.1038/nm1185.
Asghar, A. & Sheikh, N. (2017). Role of immune cells in obesity induced low grade inflammation and insulin resistance. Cell Immunol, 315(1),18-26. DOI: 10.1016/j.cellimm.2017.03.001.
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., Steppan, C. M., Ahima, R. S., Obici, S., Rossetti, L., Lazar, M. A. (2004). Regulation of fasted blood glucose by resistin. Science, 303(5661), 1195-1198. DOI: 10.1126/science.1092341.
Beilharz, J. E., Maniam, J. & Morris, M. J. (2016). Short-term exposure to a diet high in fat and sugar, or liquid sugar, selectively impairs hippocampal-dependent memory, with differential impacts on inflammation. Behav Brain Res, 306(1), 1-7. DOI: 10.1016/j.bbr.2016.03.018.
Bjørbaek, C., Elmquist, J. K., Frantz, J. D., Shoelson, S. E. & Flier, J. S. (1998). Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell, 1(4), 619-625. DOI: 10.1016/s1097-2765(00)80062-3.
Bjørbaek, C., Lavery, H. J., Bates, S. H., Olson, R. K., Davis, S. M., Flier, J. S. & Myers, M. G. Jr. (2000). SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem, 275(51), 40649-40657. DOI: 10.1074/jbc.M007577200.
Blaslov, K., Bulum, T. & Duvnjak, L. (2015). The role of endothelial dysfunction driven by adipocitokines in the development and progression of microvascular complications in patients with type 1 and type 2 diabetes. Med Hypotheses, 84(6), 593-595. DOI: 10.1016/j.mehy.2015.03.007.
Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U. & Tarkowski, A. (2005). Resistin, an adipokine with potent proinflammatory properties. J Immunol, 174(9), 5789-5795. DOI: 10.4049/jimmunol.174.9.5789.
Brunetti, L., Orlando, G., Ferrante, C., Recinella, L., Leone, S., Chiavaroli, A., Di Nisio, C., Shohreh, R., Manippa, F., Ricciuti, A. & Vacca, M. (2013). Orexigenic effects of omentin-1 related to decreased CART and CRH gene expression and increased norepinephrine synthesis and release in the hypothalamus. Peptides, 44(1), 66-74. DOI: 10.1016/j.peptides.2013.03.019.
15. Carlin, J. L., Grissom, N., Ying, Z., Gomez-Pinilla, F. & Reyes, T. M. (2016). Voluntary exercise blocks Western diet-induced gene expression of the chemokines CXCL10 and CCL2 in the prefrontal cortex. Brain Behav Immun, 58(1), 82-90. DOI: 10.1016/j.bbi.2016.07.161.
16. Caro, J. F., Kolaczynski, J. W., Nyce, M. R., Ohannesian, J. P., Opentanova, I., Goldman, W. H., Lynn, R. B., Zhang, P. L., Sinha, M. K. & Considine, R. V. (1996). Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet, 348(9021), 159-161. DOI: 10.1016/s0140-6736(96)03173-x.
17. Castro, G. C., Areias, M. F., Weissmann, L., Quaresma, P. G., Katashima, C. K., Saad, M. J. & Prada, P. O. (2013). Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats. FEBS Open Bio, 3(4), 443-449. DOI: 10.1016/j.fob.2013.09.002.
18. Chang, S. Y., Kim, D. B., Ko, S. H., Jang, H. J., Jo, Y. H. & Kim, M. J. (2016). The level of nitric oxide regulates lipocalin-2 expression under inflammatory condition in RINm5F beta-cells. Biochem Biophys Res Commun, 76(1), 7-14. DOI: 10.1016/j.bbrc.2016.05.110.
19. Cheng, J., Nanayakkara, G., Shao, Y., Cueto, R., Wang, L., Yang, W. Y., Tian, Y., Wang & H., Yang, X. (2017). Mitochondrial proton leak plays a critical role in pathogenesis of cardiovascular diseases. Adv Exp Med Biol, 9(8), 359-370. DOI: 10.1007/978-3-319-55330-6_20.
20. Cheng, L., Xing, H., Mao, X., Li, L., Li, X. & Li, Q. (2015). Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model. Scand J Immunol, 81(1), 31-38. DOI: 10.1111/sji.12245.
21. Chow, B. W. & Gu, C. (2015). The molecular constituents of the blood-brain barrier. Trends Neurosci, 38(10), 598-608. DOI: 10.1016/j.tins.2015.08.003.
22. Christ, A., Lauterbach, M. & Latz, E. (2019). Western Diet and the Immune System: An Inflammatory Connection. Immunity, 51(5), 794-811. DOI: 10.1016/j.immuni.2019.09.020.
23. Chung, S., Lapoint, K., Martinez, K., Kennedy, A., Boysen Sandberg, M. & McIntosh, M. K. (2006). Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology, 147(11), 5340-5351. DOI: 10.1210/en.2006-0536.
24. Cotillard, A., Poitou, C., Torcivia, A., Bouillot, J. L., Dietrich, A., Klöting, N., Grégoire, C., Lolmede, K., Blüher, M. & Clément, K. (2014). Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab, 99(8), 1466-1470. DOI: 10.1210/jc.2014-1074.
25. Cowland, J. B., Muta, T. & Borregaard, N. (2006). IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol, 176(9), 5559-5566. DOI: 10.4049/jimmunol.176.9.5559.
26. Crewe, C., Funcke, J. B., Li, S., Joffin, N., Gliniak, C. M., Ghaben, A. L., An, Y. A., Sadek, H. A., Gordillo, R., Akgul, Y., Chen, S., Samovski, D., Fischer-Posovszky, P., Kusminski, C. M., Klein, S. & Scherer, P.E. (2021). Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab. 7(9). 1853-1868.e11. DOI: 10.1016/j.cmet.2021.08.002.
27. De Souza Batista, C. M., Yang, R. Z., Lee, M. J., Glynn, N. M., Yu, D. Z., Pray, J., Ndubuizu, K., Patil, S., Schwartz, A., Kligman, M., Fried, S. K., Gong, D. W., Shuldiner, A. R., Pollin, T. I. & McLenithan, J. C. (2007). Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 56(6), 1655-1661. DOI: 10.2337/db06-1506.
29. Dimova, R. & Tankova, T. (2015). The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis. Biomed Res Int, 8(2), 1-7 DOI: 10.1155/2015/823481.
30. Enomoto, T., Ohashi, K., Shibata, R., Higuchi, A., Maruyama, S., Izumiya, Y., Walsh, K., Murohara, T. & Ouchi, N. (2011). Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J Biol Chem, 286(40), 34552-34558. DOI: 10.1074/jbc.M111.277319.
32. Fischer-Posovszky, P., Wang, Q. A., Asterholm, I. W., Rutkowski, J. M. & Scherer, P. E. (2011). Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages. Endocrinology, 152(8), 3074-3081. DOI: 10.1210/en.2011-1031.
33. Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q. & Griendling, K. K. (2018). Reactive oxygen species in metabolic and inflammatory signaling. Circ Res, 122(6), 877-902. DOI: 10.1161/CIRCRESAHA.117.311401.
34. Francisco, V., Pino, J., Gonzalez-Gay, M. A., Mera, A., Lago, F., Gómez, R., Mobasheri, A. & Gualillo, O. (2018). Adipokines and inflammation: is it a question of weight? Br J Pharmacol, 175(10), 1569-1579. DOI: 10.1111/bph.14181.
35. Friedman, J. M. (1998). Leptin, leptin receptors, and the control of body weight. Nutr Rev, 56(2), 38-46. DOI: 10.1111/j.1753-4887.1998.tb01685.x.
36. Fritsch, J., Garces, L., Quintero, M. A., Pignac-Kobinger, J., Santander, A. M., Fernández, I., Ban, Y. J., Kwon, D., Phillips, M. C., Knight, K., Mao, Q., Santaolalla, R., Chen, X. S., Maruthamuthu, M., Solis, N., Damas, O. M., Kerman, D. H., Deshpande, A. R., Lewis, J. E., Chen, C. & Abreu, M. T. (2021). Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol, 9(6), 1189-1199. DOI: 10.1016/j.cgh.2020.05.026.
37. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M. & Shimomura, I. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 114(12), 1752-1761. DOI: 10.1172/JCI21625.
38. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M. & Shimomura, I. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 114(12), 1752-1761. DOI: 10.1172/JCI21625.
39. Gao, C. L., Zhu, C., Zhao, Y. P., Chen, X. H., Ji, C. B., Zhang, C. M., Zhu, J. G., Xia, Z. K., Tong, M. L., Guo, X. R. (2010). Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Mol Cell Endocrinol, 320(2), 25-33. DOI: 10.1016/j.mce.2010.01.039.
40. Garcia, D. & Shaw, R. J. (2017). AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell, 66(6), 789–800. DOI: 10.1016/j.molcel.2017.05.032.
41. Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T. & Kiess, W. (2015). Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol, 11(9), 535-546. DOI: 10.1038/nrendo.2015.117.
42. Ghosh, S. & Bouchard, C. (2017). Convergence between biological, behavioural and genetic determinants of obesity. Nat Rev Genet, 18(1), 731-748. DOI: 10.1038/nrg.2017.72.
43. Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F. Q., Bombelli, M., Scopelliti, F., Facchini, A., Mancia, G. (2003). Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens, 21(9), 1761-1769. DOI: 10.1097/00004872-200309000-00027.
44. Green, M., Arora, K., Prakash, S. (2020). Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome. Int J Mol Sci, 21(8), 2878-2890. DOI: 10.3390/ijms21082890.
45. Guilherme, A., Virbasius, J. V., Puri, V. & Czech, M. P. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol, 9(5), 367-377. DOI: 10.1038/nrm2391.
46. Hao, S., Dey, A., Yu, X. & Stranahan, A. M. (2016). Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity. Brain Behav Immun, 51(1), 230-239. DOI: 10.1016/j.bbi.2015.08.023.
47. Hardy, O. T., Czech, M. P. & Corvera, S. (2012). What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes, 19(2), 81-87. DOI: 10.1097/MED.0b013e3283514e13.
49. Hector, J., Schwarzloh, B., Goehring, J., Strate, T. G., Hess, U. F., Deuretzbacher, G., Hansen-Algenstaedt, N., Beil, F. U. & Algenstaedt, P. (2007). TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res, 39(4), 250-255. DOI: 10.1055/s-2007-973075.
50. Heinonen, S., Jokinen, R., Rissanen, A. & Pietiläinen, K. H. (2020). White adipose tissue mitochondrial metabolism in health and in obesity. Obes Rev. 21(2) 113-128. DOI: 10.1111/obr.12958.
51. Herder, C., Ouwens, D. M., Carstensen, M., Kowall, B., Huth, C., Meisinger, C., Rathmann, W., Roden, M. & Thorand, B. (2015). Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol, 172(4), 423-432. DOI: 10.1530/EJE-14-0879.
52. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M. & Hotamisligil, G.S. (2002) A central role for JNK in obesity and insulin resistance. Nature, 420(6913), 333-336. DOI: 10.1038/nature01137.
53. Horio, E., Kadomatsu, T., Miyata, K., Arai, Y., Hosokawa, K., Doi, Y., Ninomiya, T., Horiguchi, H., Endo, M., Tabata, M., Tazume, H., Tian, Z., Takahashi, O., Terada, K., Takeya, M., Hao, H., Hirose, N., Minami, T., Suda, T., Kiyohara, Y., Ogawa, H., Kaikita, K. & Oike, Y. (2014). Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol, 34(4), 790-800. DOI: 10.1161/ATVBAHA.113.303116.
54. Horowitz, J. F. & Klein, S. (2000). Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am J Physiol Endocrinol Metab, 278(6), 1144-1152. DOI: 10.1152/ajpendo.2000.278.6.E1144.
55. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860-867. DOI: 10.1038/nature05485.
56. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F. & Spiegelman, B. M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science, 271(5249), 665-668. DOI: 10.1126/science.271.5249.665.
57. Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259(5091), 87-91. DOI: 10.1126/science.7678183.
58. Hsu, T. M. & Kanoski, S. E. (2014). Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia. Front Aging Neurosci, 6(88). 1-6 DOI: 10.3389/fnagi.2014.00088.
59. Jais, A., Solas, M., Backes, H., Chaurasia, B., Kleinridders, A., Theurich, S., Mauer, J., Steculorum, S. M., Hampel, B., Goldau, J., Alber, J., Förster, C. Y., Eming, S. A., Schwaninger, M., Ferrara, N., Karsenty, G. & Brüning, J. C. (2016). Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell, 165(4), 882-895. DOI: 10.1016/j.cell.2016.03.033.
60. Januzzi, J.L. Jr, & Mohebi, R. (2021). Obesity-mediated disruption of natriuretic peptide-blood pressure rhythms. J Am Coll Cardiol, 77(18). 2304-2306. DOI: 10.1016/j.jacc.2021.03.317.
61. Jastroch, M., Divakaruni, A. S., Mookerjee, S., Treberg, J. R. & Brand, M. D. (2010). Mitochondrial proton and electron leaks. Essays Biochem, 47(1), 53-67. DOI: 10.1042/bse0470053.
62. Jayaraman, A., Lent-Schochet, D. & Pike, C. J. (2014). Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. J Neuroinflammation, 11(162), 1-14. DOI: 10.1186/s12974-014-0162-y.
63. Kadowaki, T., Yamauchi, T. & Kubota, N. (2008). The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett, 582(1), 74-80. DOI: 10.1016/j.febslet.2007.11.070.
64. Kanoski, S. E. & Davidson, T. L. (2011). Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav, 103(1), 59-68. DOI: 10.1016/j.physbeh.2010.12.003.
65. Karczewski, J., Śledzińska, E., Baturo, A., Jończyk, I., Maleszko, A., Samborski, P., Begier-Krasińska, B. & Dobrowolska, A. (2018). Obesity and inflammation. Eur Cytokine Netw, 29(3), 83-94. DOI: 10.1684/ecn.2018.0415.
66. Kaser, S., Kaser, A., Sandhofer, A., Ebenbichler, C. F., Tilg, H. & Patsch, J. R. (2003). Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun, 309(2), 286-290. DOI: 10.1016/j.bbrc.2003.07.003.
67. Kawai, T., Autieri, M. V. & Scalia, R. (2021). Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol, 320(3), 375-391. DOI: 10.1152/ajpcell.00379.2020.
68. Kazama, K., Usui, T., Okada, M., Hara, Y. & Yamawaki H. (2012). Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol, 686(3), 116-123. DOI: 10.1016/j.ejphar.2012.04.033.
69. Könner, A. C. & Brüning, J. C. (2011). Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab, 22(1), 16-23. DOI: 10.1016/j.tem.2010.08.007.
70. Kotas, M. E. & Medzhitov, R (2015). Homeostasis, inflammation, and disease susceptibility. Cell, 160(5), 816-827. DOI: 10.1016/j.cell.2015.02.010.
71. Kusku-Kiraz, Z., Genc, S., Bekpinar, S., Unlucerci, Y., Olgac, V., Uysal, M. & Gurdol, F. (2015). Circulating levels of apelin, glucagon-like peptide and visfatin in hypercholesterolemic-hyperhomocysteinemic guinea-pigs: their relation with NO metabolism. Mol Cell Biochem, 400(2), 69-75. DOI: 10.1007/s11010-014-2263-4.
74. Law, I. K., Xu, A., Lam, K. S., Berger, T., Mak, T. W., Vanhoutte, P. M., Liu, J. T., Sweeney, G., Zhou, M., Yang, B. & Wang, Y. (2010). Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes, 59(4), 872-82. DOI: 10.2337/db09-1541.
75. Lee, J. H., Zhang, Y., Zhao, Z., Ye, X., Zhang, X., Wang, H. & Ye, J. (2017). Intracellular ATP in balance of pro- and anti-inflammatory cytokines in adipose tissue with and without tissue expansion. Int J Obes, 41(4), 645–651. DOI: 10.1038/ijo.2017.3.
76. Leigh, S. J. & Morris, M. J. (2020). Diet, inflammation and the gut microbiome: Mechanisms for obesity-associated cognitive impairment. Biochim Biophys Acta Mol Basis Dis, 2(3), 1866-1896. DOI: 10.1016/j.bbadis.2020.165767.
77. Li, H., Xiao, Y., Tang, L., Zhong, F., Huang, G., Xu, J. M., Xu, A. M., Dai, R. P. & Zhou, Z. G. (2018). Adipocyte fatty acid-binding protein promotes palmitate-induced mitochondrial dysfunction and apoptosis in macrophages. Front Immunol. 9(8). 1122-1135. DOI: 10.3389/fimmu.2018.00081.
78. Li, P., Liu, S., Lu, M., Bandyopadhyay, G., Oh, D., Imamura, T., Johnson, A. M. F., Sears, D., Shen, Z., Cui, B., Kong, L., Hou, S., Liang, X., Iovino, S., Watkins, S. M., Ying, W., Osborn, O., Wollam, J., Brenner, M. & Olefsky. J. M. (2016). Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance. Cell, 167(4), 973-984.e12. DOI: 10.1016/j.cell.2016.10.025.
79. Li, P., Oh, D. Y., Bandyopadhyay, G., Lagakos, W. S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Maris, M., Ofrecio, J. M., Taguchi, S., Lu, M. & Olefsky, J.M. (2015). LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat Med, 21(3), 239-247. DOI: 10.1038/nm.3800.
80. Lin, Y., Berg, A. H., Iyengar, P., Lam, T. K., Giacca, A., Combs, T. P., Rajala, M. W., Du, X., Rollman, B., Li, W., Hawkins, M., Barzilai, N., Rhodes, C. J., Fantus, I. G., Brownlee, M. & Scherer, P. E. (2005). The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem, 280(6), 4617-4626. DOI: 10.1074/jbc.M411863200.
81. Lindhorst, A., Raulien, N., Wieghofer, P., Eilers, J., Rossi, F. M. V., Bechmann, I. & Gericke, M. (2021). Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages. Cell Death Dis, 12(6), 562-579. DOI: 10.1038/s41419-021-03872-9.
. Liu, R., Nikolajczyk, B. S. (2019). Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol, 10(2), 15-37. DOI: 10.3389/fimmu.2019.01587.
83. Lo, J., Bernstein, L. E., Canavan, B., Torriani, M., Jackson, M. B., Ahima, R. S. & Grinspoon, S. K. (2007). Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab, 293(1) 102-109. DOI: 10.1152/ajpendo.00089.2007.
84. Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F. & Miele, C. (2019). Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci, 20(9), 23-58. DOI: 10.3390/ijms20092358.
86. Lowell, B. B & Bachman, E. S. (2003). Beta-Adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem, 278(32), 29385-29388. DOI: 10.1074/jbc.R300011200.
87. Lu, Q., Li, M., Zou, Y. & Cao, T (2014). Induction of adipocyte hyperplasia in subcutaneous fat depot alleviated type 2 diabetes symptoms in obese mice. Obesity, 22(7), 1623-1631. DOI: 10.1002/oby.20705.
89. Lumeng, C. N. & Saltiel, A. R. (2011). Inflammatory links between obesity and metabolic disease. J Clin Invest, 121(6), 2111-2117. DOI: 10.1172/JCI57132.
90. Lumeng, C. N. & Saltiel, A. R. (2011). Inflammatory links between obesity and metabolic disease. J Clin Invest, 121(6), 2111-2117. DOI: 10.1172/JCI57132.
91. Malesza, I. J., Malesza, M., Walkowiak, J., Mussin, N., Walkowiak, D., Aringazina, R., Bartkowiak-Wieczorek, J. & Mądry, E. (2021). High-fat, western-style diet, systemic inflammation, and gut microbiota: A narrative review. Cells, 10(11), 31-64. DOI: 10.3390/cells10113164.
92. Mastrototaro L. & Roden M. (2021). Insulin resistance and insulin sensitizing agents. Metabolism, 1(25), 1-15. DOI: 10.1016/j.metabol.2021.154892.
93. Mayoral, L. P., Andrade, G. M., Mayoral, E. P., Huerta, T. H., Canseco, S. P., Rodal Canales, F. J., Cabrera-Fuentes, H. A., Cruz, M. M., Pérez Santiago, A. D., Alpuche, J. J., Zenteno, E., Ruíz, H. M., Cruz, R. M., Jeronimo, J. H. & Perez-Campos, E. (2020). Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res, 151(1), 11-21. DOI: 10.4103/ijmr.IJMR_1768_17.
94. McMurray, F., Patten, D. A. & Harper, M. E. (2016). Reactive oxygen species and oxidative stress in obesity-recent findings and empirical approaches. Obesity, 24(11), 2301-2310. DOI: 10.1002/oby.21654.
95. Mittendorfer, B., Horowitz, J. F., DePaoli, A. M., McCamish, M. A., Patterson, B.W. & Klein S. (2011). Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes. Diabetes, 60(5), 1474–1477. DOI: 10.2337/db10-1302.
96. Mohapatra, J., Sharma, M., Acharya, A., Pandya, G., Chatterjee, A., Balaraman, R. & Jain, M. R. (2011). Retinol-binding protein 4 : a possible role in cardiovascular complications. Br J Pharmacol, 164(8), 1939-1948. DOI: 10.1111/j.1476-5381.2011.01492.x.
97. Myers, M. G., Cowley, M. A. & Münzberg, H. (2008). Mechanisms of leptin action and leptin resistance. Annu Rev Physiol, 70(1), 537-556. DOI: 10.1146/annurev.physiol.70.113006.100707.
98. Nakamura, K., Fuster, J. J. & Walsh, K. (2014). Adipokines: a link between obesity and cardiovascular disease. J Cardiol, 63(4), 25025-9. DOI: 10.1016/j.jjcc.2013.11.006.
99. Nov, O., Shapiro, H., Ovadia, H., Tarnovscki, T., Dvir, I., Shemesh, E., Kovsan, J., Shelef, I., Carmi, Y., Voronov, E., Apte, R. N., Lewis, E., Haim, Y., Konrad, D., Bashan, N. & Rudich, A. (2013). Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PLoS One, 8(1), 1-12. DOI: 10.1371/journal.pone.0053626.
100. Nway, N. C., Sitticharoon, C., Chatree, S. & Maikaew, P. (2016). Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues. Obes Res Clin Pract, 10(3), 256-263. DOI: 10.1016/j.orcp.2015.05.007.
107. Olefsky, J. M. & Glass, C. K. (2010). Macrophages, inflammation, and insulin resistance. Annu Rev Physiol, 72(1), 219-246. DOI: 10.1146/annurev-physiol-021909-135846.
108. Olszanecka-Glinianowicz, M., Kocełak, P., Nylec, M., Chudek, J. & Zahorska-Markiewicz, B. (2012). Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome. Arch Med Sci, 8(2), 214-218. DOI: 10.5114/aoms.2012.28547.
109. Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., Gorden, P. & Garg, A. (2002). Leptin-replacement therapy for lipodystrophy. N Engl J Med, 346(8), 570-578. DOI: 10.1056/NEJMoa012437.
110. Ortega, F. J., Moreno-Navarrete, J. M., Ribas, V., Esteve, E., Rodriguez-Hermosa, J. I., Ruiz, B., Peral, B., Ricart, W., Zorzano, A. & Fernández-Real, J. M. (2009). Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat. Obesity, 17(12), 2134-2141. DOI: 10.1038/oby.2009.110.
111. Öst, A., Danielsson, A., Lidén, M., Eriksson, U., Nystrom, F. H. & Strålfors, P. (2007). Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J, 21(13), 3696-3704. DOI: 10.1096/fj.07-8173com.
112. Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y. & Walsh, K. (2003). Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol, 14(6), 561-566. DOI: 10.1097/00041433-200312000-00003.
113. Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nat Rev Immunol, 11(2), 85-97. DOI: 10.1038/nri2921.
114. Panidis, D., Farmakiotis, D., Rousso, D., Katsikis, I., Delkos, D., Piouka, A., Gerou, S. & Diamanti-Kandarakis, E. (2008). Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Intern Med, 19(6), 406-412. DOI: 10.1016/j.ejim.2007.05.014.
116. Piché, M. E., Tchernof, A., Després, J. P. (2020). Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res, 126(11), 1477-1500. DOI: 10.1161/CIRCRESAHA.120.316101.
117. Pistell, P. J., Morrison, C. D., Gupta, S., Knight, A. G., Keller, J. N., Ingram, D. K. & Bruce-Keller, A. J. (2010). Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol, 219(2), 25-32. DOI: 10.1016/j.jneuroim.2009.11.010.
118. Poloni, A., Maurizi, G., Mattiucci, D., Busilacchi, E., Mancini, S., Discepoli, G., Amici, A., Falconi, M., Cinti, S. & Leoni, P. (2015). Biosafety evidence for human dedifferentiated adipocytes. J Cell Physiol, 230(7), 1525-1533. DOI: 10.1002/jcp.24898.
119. Quadro, L., Blaner, W. S., Salchow, D. J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M. P., Colantuoni, V. & Gottesman, M. E. (1999). Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J, 18(17), 4633-4644. DOI: 10.1093/emboj/18.17.4633.
120. Quinlan, C. L., Perevoshchikova, I. V., Hey-Mogensen, M., Orr, A. L. & Brand, M. D. (2013). Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol, 1(1), 304-312. DOI: 10.1016/j.redox.2013.04.005.
121. Rahmouni, K., Correia, M. L., Haynes, W. G. & Mark, A. L. (2005). Obesity-associated hypertension: new insights into mechanisms. Hypertension, 45(1), 9-14. DOI: 10.1161/01.HYP.0000151325.83008.b4.
122. Raitakari, M., Ilvonen, T., Ahotupa, M., Lehtimäki, T., Harmoinen, A., Suominen, P., Elo, J., Hartiala, J. & Raitakari, O. T. (2004). Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol, 24(1), 124-128. DOI: 10.1161/01.ATV.0000109749.11042.7c.
123. Reilly, S. M. & Saltiel, A. R. (2017). Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol,13(11), 633-643. DOI: 10.1038/nrendo.2017.90.
124. Reuter, S. & Mrowka, R. Obesity, adipocytes and insulin resistance-Friends for life? Acta Physiol (Oxf), 225(3), 1-7. DOI: 10.1111/apha.13258.
125. Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., Milbrandt, J., Kiess, W. & Imai, S. (2007). Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab, 6(5), 363-375. DOI: 10.1016/j.cmet.2007.09.003.
126. Roager, H. M., Vogt, J. K., Kristensen, M., Hansen, L. B. S., Ibrügger, S., Mærkedahl, R. B., Bahl, M. I., Lind, M. V., Nielsen, R. L., Frøkiær, H., Gøbel, R. J., Landberg, R., Ross, A. B., Brix, S., Holck, J., Meyer, A. S., Sparholt, M. H., Christensen, A. F., Carvalho, V., Hartmann, B., Holst, J. J., Rumessen, J. J., Linneberg, A., Sicheritz-Pontén, T., Dalgaard, M. D., Blennow, A., Frandsen, H. L., Villas-Bôas, S., Kristiansen, K., Vestergaard, H., Hansen, T., Ekstrøm, C. T., Ritz, C., Nielsen, H. B., Pedersen, O. B., Gupta, R., Lauritzen, L. & Licht, T. R. (2019). Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial. Gut, 68(1), 83-93. DOI: 10.1136/gutjnl-2017-314786.
127. Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y. & Funahashi, T. (2004). Adiponectin as a biomarker of the metabolic syndrome. Circ J, 68(11), 975-981. DOI: 10.1253/circj.68.975.
128. Rytka, J. M., Wueest, S., Schoenle, E. J. & Konrad, D. (2011). The portal theory supported by venous drainage-selective fat transplantation. Diabetes, 60(1), 56-63. DOI: 10.2337/db10-0697.
131. Schmitz, J., Evers, N., Awazawa, M., Nicholls, H. T., Brönneke, H. S., Dietrich, A., Mauer, J., Blüher, M. & Brüning, J. C. (2016). Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss. Mol Metab, 5(5), 328-339. DOI: 10.1016/j.molmet.2015.12.001.
132. Schwartz, M. W., Seeley, R. J., Zeltser, L. M., Drewnowski, A., Ravussin, E., Redman, L. M., & Leibel, R. L. (2017). Obesity pathogenesis: An endocrine society scientific statement. Endocrine reviews, 38(4), 267–296. DOI:10.1210/er.2017-00111.
133. Shenoy, U. & Cassis, L. (1997). Characterization of renin activity in brown adipose tissue. Am J Physiol, 272(3), 989-999. DOI: 10.1152/ajpcell.1997.272.3.C989.
134. Shibata, R., Ouchi, N., Ohashi, K. & Murohara, T. (2017). The role of adipokines in cardiovascular disease. J Cardiol, 70(4), 329-334. DOI: 10.1016/j.jjcc.2017.02.006.
135. Sikaris, K. A. (2004). The clinical biochemistry of obesity. Clin Biochem Rev, 25(1), 165-181. DOI: 10.134.CBR.2004.12.009.
136. Smith, U. & Kahn, B. B. (2016). Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J Intern Med, 280(5), 465-475. DOI: 10.1111/joim.12540.
137. Song, T. & Kuang, S. (2019). Adipocyte dedifferentiation in health and diseases. Clin Sci, 133(20), 2107-2119. DOI: 10.1042/CS20190128.
138. Speretta, G. F., Silva, A. A., Vendramini, R. C., Zanesco, A., Delbin, M. A., Menani, J. V., Bassi, M., Colombari, E. & Colombari, D. S. (2016). Resistance training prevents the cardiovascular changes caused by high-fat diet. Life Sci, 146(2), 154-162. DOI: 10.1016/j.lfs.2016.01.011.
139. Stanley, T. L., Zanni, M. V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., Khor, V. K., Ahima, R. S. & Grinspoon, S. K. (2011). TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab, 96(1), 146-150. DOI: 10.1210/jc.2010-1170.
140. Starkov, A. A., Fiskum, G., Chinopoulos, C., Lorenzo, B. J., Browne, S. E., Patel, M. S., Beal, M. F. (2004). Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci, 24(36), 7779-7788. DOI: 10.1523/JNEUROSCI.1899-04.2004.
141. Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J. & Lazar, M. A. (2005). Activation of SOCS-3 by resistin. Mol Cell Biol, 25(4), 1569-1575. DOI: 10.1128/MCB.25.4.1569-1575.2005.
143. Suski, J. M., Lebiedzinska, M., Bonora, M., Pinton, P., Duszynski, J. & Wieckowski, M. R. (2012). Relation between mitochondrial membrane potential and ROS formation. Methods Mol Biol, 8(10), 183-205. DOI: 10.1007/978-1-61779-382-0_12.
144. Szulinska, M., Musialik, K., Suliburska, J., Lis, I. & Bogdanski, P. (2014). The effect of L-arginine supplementation on serum resistin concentration in insulin resistance in animal models. Eur Rev Med Pharmacol Sci, 18(4), 575-80. DOI: 10. 24610624.ERMFS.7002.
145. Tabata, M., Kadomatsu, T., Fukuhara, S., Miyata, K., Ito, Y., Endo, M., Urano, T., Zhu, H. J., Tsukano, H., Tazume, H., Kaikita, K., Miyashita, K., Iwawaki, T., Shimabukuro, M., Sakaguchi, K., Ito, T., Nakagata, N., Yamada, T., Katagiri, H., Kasuga, M., Ando, Y., Ogawa, H., Mochizuki, N., Itoh, H., Suda, T. & Oike, Y. (2009). Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab, 10(3), 178-188. DOI: 10.1016/j.cmet.2009.08.003.
146. Talior, I., Yarkoni, M., Bashan, N. & Eldar-Finkelman, H. (2003). Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab, 285(2), 295-302. DOI: 10.1152/ajpendo.00044.2003.
147. Tchkonia, T., Thomou, T., Zhu, Y., Karagiannides, I., Pothoulakis, C., Jensen, M. D. & Kirkland, J.L. (2013). Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab, 17(5), 644-656. DOI: 10.1016/j.cmet.2013.03.008.
149. Tian, Z., Miyata, K., Tazume, H., Sakaguchi, H., Kadomatsu, T., Horio, E., Takahashi, O., Komohara, Y., Araki, K., Hirata, Y., Tabata, M., Takanashi, S., Takeya, M., Hao, H., Shimabukuro, M., Sata, M., Kawasuji, M. & Oike, Y. (2013). Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol, 57(1), 1-12. DOI: 10.1016/j.yjmcc.2013.01.004.
151. Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M. & Dixit, V. D. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med, 17(2), 179-188. DOI: 10.1038/nm.2279.
152. Wang, L., Wang, S., Shi, Y., Li, R., Günther, S., Ong, Y. T., Potente, M., Yuan, Z., Liu, E., Offermanns, S. (2020). YAP and TAZ protect against white adipocyte cell death during obesity. Nat Commun, 11(1), 5442-5455. DOI: 10.1038/s41467-020-19229-3.
153. Wang, S., Huang, X. F., Zhang, P., Wang, H., Zhang, Q., Yu, S. & Yu, Y. (2016). Chronic rhein treatment improves recognition memory in high-fat diet-induced obese male mice. J Nutr Biochem, 36(1), 42-50. DOI: 10.1016/j.jnutbio.2016.07.008.
181. Wang, T., Si, Y., Shirihai, O. S., Si, H., Schultz, V., Corkey, R. F., Hu, L., Deeney, J. T., Guo, W. & Corkey, B. E. (2010). Respiration in adipocytes is inhibited by reactive oxygen species. Obesity, 18(8), 1493-1502. DOI: 10.1038/oby.2009.456.
154. Wei, Z., Peterson, J. M., Lei, X., Cebotaru, L., Wolfgang, M. J., Baldeviano, G. C. & Wong, G. W. (2012). C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes. J Biol Chem, 287(13), 10301-10315. DOI: 10.1074/jbc.M111.303651.
155. WHO, Obesity and overweight. 2017. http://wwwwhoint/newsroom/fact-sheets/detail/obesity-and-overweight.
156. Yamaguchi, N., Argueta, J. G. M., Masuhiro, Y., Kagishita, M., Nonaka, K., Saito, T., Hanazawa, S. & Yamashita, Y. (2005). Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS letters, 579(30), 6821–6826. DOI: 10.1016/j.febslet.2005.11.019.
157. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R. & Kadowaki T. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423(6941), 762-769. DOI: 10.1038/nature01705.
158. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B. B. & Kadowaki T. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 8(11), 1288-1295. DOI: 10.1038/nm788.
159. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010 Mar 19;393(4):668-72. doi: 10.1016/j.bbrc.2010.02.053.
160. Yamawaki, H., Kuramoto, J., Kameshima, S., Usui, T., Okada, M. & Hara, Y. (2011). Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun, 408(2), 339-343. DOI: 10.1016/j.bbrc.2011.04.039.
161. Yang, R. Z., Lee, M. J., Hu, H., Pray, J., Wu, H. B., Hansen, B. C., Shuldiner, A. R., Fried, S. K., McLenithan, J. C. & Gong, D. W. (2006). Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 290(6), 1253-1261. DOI: 10.1152/ajpendo.00572.2004.
162. Ye, J. (2021). Mechanism of insulin resistance in obesity: a role of ATP. Front Med, 15(3), 372-382. DOI: 10.1007/s11684-021-0862-5.
163. Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. (2011). Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab, 14(4), 528-536. DOI: 10.1016/j.cmet.2011.08.014.
164. Yu, E., Ley, S. H., Manson, J. E., Willett, W., Satija, A., Hu, F. B. & Stokes, A. (2017). Weight history and all-cause and cause-specific mortality in three prospective cohort studies. Ann Intern Med, 166(9), 613-620. DOI: 10.7326/M16-1390.
165. Zamarron, B. F., Mergian, T. A., Cho, K. W., Martinez-Santibanez, G., Luan, D., Singer, K., DelProposto, J. L., Geletka, L. M., Muir, L. A. & Lumeng, C. N. (2017). Macrophage proliferation sustains adipose tissue inflammation in formerly obese mice. Diabetes, 66(2), 392-406. DOI: 10.2337/db16-0500.
166. Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H. & Cai, D. (2008). Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell, 135(1), 61-73. DOI: 10.1016/j.cell.2008.07.043.
167. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372(6505), 425-342. DOI: 10.1038/372425a0.
168. Zick, Y. (2005). Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE, 2005(268), 1-4. DOI: 10.1126/stke.2682005pe4.
Derechos de autor 2023 Wendy A. García-Ortega;José Ángel Angulo-Camacho ;Alfredo Ibarra-Sánchez
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.jpg)
